|
Volumn 33, Issue 5, 2001, Pages 2778-2779
|
Therapeutic drug level monitoring for mycophenolate mofetil: Is it justified?
a a a a a a
a
RIZK HOSPITAL
(Lebanon)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ADULT;
AGED;
CADAVER DONOR;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DRUG BLOOD LEVEL;
DRUG MONITORING;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GRAFT REJECTION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LIVING DONOR;
MALE;
PRIORITY JOURNAL;
ADULT;
AGED;
AZATHIOPRINE;
DRUG MONITORING;
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
REOPERATION;
|
EID: 0034899481
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02188-1 Document Type: Conference Paper |
Times cited : (5)
|
References (15)
|